Bought
Maintained
Sold
Other funds holding G
NIEF
Xponance's G Position: Q2 2026 in Review
Xponance reduced its Genpact (G) stake by 2.2% in Q2 2026, selling an estimated $14.7K and leaving 19,558 shares worth $538K. The position accounts for ﹤0.01% of the portfolio, ranked #1072.
Xponance first reported a position in G in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.5M in Q4 2022. 480 funds tracked by Wall St. Rank hold G as of Q2 2026.
- Xponance held 19,558 shares of Genpact worth $538K as of Q2 2026.
- Xponance sold 448 Genpact shares in Q2 2026, an estimated $14.7K.
- Genpact made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1072 holding.
- Xponance first reported a position in Genpact in Q2 2020 and has held it in 25 quarters since.
- Xponance's Genpact position peaked at $1.5M in Q4 2022.
- 480 funds tracked by Wall St. Rank held Genpact as of Q2 2026.
Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.